Succeed With Xarelto Lawsuit In 24 Hours

Our attorneys have filed a mass tort lawsuit on behalf of click here! patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning difficult to acquire those hurt by the drug the compensation they may be entitled to. Whilst bleeding is a frequent complication related with anticoagulants, it has been alleged that Xarelto is much more unsafe than classic blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, individuals may be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging. In the event you or even a loved one suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For a lot more details, make contact with us today to possess your case reviewed, free of charge of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral costs. Moreover, they are in search of punitive damages, that are usually awarded to punish the defendant and deter other organizations from acting similarly. Why Are Lawsuits Getting Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a protected anticoagulant option. Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion. Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting. Visit this page for more details on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.